What happened
Versigent PLC (NYSE: VGNT) director Kevin P. Clark sold 97,278 ordinary shares on 2026-10-07 and 2026-10-08.
The filing says Clark sold 43,692 shares at a weighted average price of $44.9 on 2026-10-07, then 5,331 at $45.68 and 494 at $46.43.
The form checks the Rule 10b5-1 box, and the filing says the plan was adopted on June 3, 2026 through the Kevin P. Clark 2002 Revocable Trust.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares sold | 97,278 shares | SEC Form 4 | |
| Sale price per share | $44.33 to $46.43 | SEC Form 4 | |
| Total value | about $4.35 million | SEC Form 4 | |
| Shares held after sale | 27,571 shares | SEC Form 4 |
Read more: Versigent (VGNT) stock analysis and investment case
Why it matters
OptimistFi's calculation shows the 97,278 shares were about 77.9% of Clark's holding before the trade, so the sale cut the stake sharply.
Clark still held 27,571 shares after the last reported sale, which keeps a direct ownership tie to the stock.
The footnotes say the sales were executed in multiple transactions at prices ranging from $44.35 to $45.34, $45.35 to $46.29, $46.38 to $46.46, $43.82 to $44.81 and $44.82 to $45.05.
The filing says the trades were made under a Rule 10b5-1 trading plan adopted on June 3, 2026 through the Kevin P. Clark 2002 Revocable Trust, so the sale may have been preset, not a fresh assessment of Versigent.
OptimistFi's case is that Versigent can create value if vehicle-program content proves sticky and cash-generative.
This filing weakens that case because it adds a large director sale and still does not prove moat, margin power or valuation support.
The sale is a holdings update, not an operating result, but it is large enough to matter for anyone tracking insider exposure.
Browse: stock research on every company OptimistFi covers
What's next
The next observable filing is Clark's next Form 4, which will show whether more sales occur under the same June 3, 2026 Rule 10b5-1 plan.
If the next filing shows more sales, the reduction deepens.
If it shows no further sales, the move looks more like a scheduled trim.
More from OptimistFi
- VGNT stock: the Versigent thesis, its status and the next test to watch
- Levi Strauss & Co. (NYSE: LEVI) Raises Profit as Wholesale Outruns DTC
- Park Aerospace Corp. (NYSE: PKE) Expands Profit as Sales Rise
- Helen of Troy Limited (NASDAQ: HELE) Lifts Profit as Cash Flow Rebounds
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC Form 4 — Statement of changes in beneficial ownership filed 2026-10-09
Read the full OptimistFi thesis on Versigent PLC: https://optimistfi.com/stocks/VGNT
See what would break the Versigent PLC thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Versigent PLC investment case, its status and the next test to watch live on the Versigent PLC thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
